Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis
- PMID: 11136718
- DOI: 10.1074/jbc.C000824200
Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis
Abstract
DNA topoisomerase II (topo II) is a ubiquitous nuclear enzyme that is involved in DNA replication, transcription, chromosome segregation, and apoptosis. Here we show by immunoprecipitation, pull down with glutathione S-transferase fusion proteins, and yeast two-hybrid analysis that both topo IIalpha and -beta physically interact with the histone deacetylase HDAC1. The in vitro DNA decatenation activity of recombinant topo IIalpha and -beta is inhibited by association with catalytically inactive, recombinant HDAC1. We provide evidence for the in vivo significance of the topo II-HDAC1 association, showing that inhibition of HDAC activity with trichostatin A suppresses apoptosis induced by the topo II poison etoposide, but not by the topoisomerase I inhibitor camptothecin. We suggest that chromatin remodeling by an HDAC-containing complex facilitates both topo II-catalyzed DNA rearrangement and etoposide-induced DNA damage in vivo.
Similar articles
-
Histone Deacetylase Inhibitors Trichostatin A and MCP30 Relieve Benzene-Induced Hematotoxicity via Restoring Topoisomerase IIα.PLoS One. 2016 Apr 8;11(4):e0153330. doi: 10.1371/journal.pone.0153330. eCollection 2016. PLoS One. 2016. PMID: 27058040 Free PMC article.
-
The histone deacetylase inhibitor sodium butyrate induces DNA topoisomerase II alpha expression and confers hypersensitivity to etoposide in human leukemic cell lines.Mol Cancer Ther. 2001 Dec;1(2):121-31. Mol Cancer Ther. 2001. PMID: 12467229
-
Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid.J Cell Biochem. 2004 May 15;92(2):223-37. doi: 10.1002/jcb.20045. J Cell Biochem. 2004. PMID: 15108350
-
Histone deacetylase interacts directly with DNA topoisomerase II.Nat Genet. 2000 Nov;26(3):349-53. doi: 10.1038/81671. Nat Genet. 2000. PMID: 11062478
-
A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.Biochem Pharmacol. 2014 Aug 1;90(3):320-30. doi: 10.1016/j.bcp.2014.06.001. Epub 2014 Jun 7. Biochem Pharmacol. 2014. PMID: 24915421
Cited by
-
Decondensing the protamine domain for transcription.Proc Natl Acad Sci U S A. 2007 May 15;104(20):8340-5. doi: 10.1073/pnas.0700076104. Epub 2007 May 1. Proc Natl Acad Sci U S A. 2007. PMID: 17483471 Free PMC article.
-
Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitors.J Med Chem. 2012 Feb 23;55(4):1465-77. doi: 10.1021/jm200799p. Epub 2012 Feb 13. J Med Chem. 2012. PMID: 22260166 Free PMC article.
-
The interplay between DNA topoisomerase 2α post-translational modifications and drug resistance.Cancer Drug Resist. 2020 Feb 27;3(2):149-160. doi: 10.20517/cdr.2019.114. eCollection 2020. Cancer Drug Resist. 2020. PMID: 35582608 Free PMC article. Review.
-
Transcriptional consequences of topoisomerase inhibition.Mol Cell Biol. 2001 Dec;21(24):8437-51. doi: 10.1128/MCB.21.24.8437-8451.2001. Mol Cell Biol. 2001. PMID: 11713279 Free PMC article.
-
Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker.Br J Cancer. 2009 Oct 6;101(7):1044-50. doi: 10.1038/sj.bjc.6605293. Epub 2009 Sep 8. Br J Cancer. 2009. PMID: 19738609 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
